Smith E, Papadimas A, Gabor C, Cooney C, Wu T, Rasko D
mSphere. 2023; 8(5):e0030223.
PMID: 37787523
PMC: 10597352.
DOI: 10.1128/msphere.00302-23.
Kumar A, Hays M, Lim F, Foster L, Zhou M, Zhu G
PLoS Negl Trop Dis. 2015; 9(8):e0003924.
PMID: 26244636
PMC: 4526226.
DOI: 10.1371/journal.pntd.0003924.
Karambu S, Matiru V, Kiptoo M, Oundo J
Pan Afr Med J. 2014; 16:37.
PMID: 24570797
PMC: 3932116.
DOI: 10.11604/pamj.2013.16.37.2947.
Konishi N, Obata H, Monma C, Nakama A, Kai A, Tsuji T
J Clin Microbiol. 2011; 49(9):3348-51.
PMID: 21752981
PMC: 3165597.
DOI: 10.1128/JCM.02576-10.
Money N, Maves R, Sebeny P, Kasper M, Riddle M, Wu M
BMC Public Health. 2011; 11 Suppl 2:S7.
PMID: 21388567
PMC: 3092417.
DOI: 10.1186/1471-2458-11-S2-S7.
Ancestral lineages of human enterotoxigenic Escherichia coli.
Steinsland H, Lacher D, Sommerfelt H, Whittam T
J Clin Microbiol. 2010; 48(8):2916-24.
PMID: 20534806
PMC: 2916599.
DOI: 10.1128/JCM.02432-09.
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.
Lapa J, Sincock S, Ananthakrishnan M, Porter C, Cassels F, Brinkley C
Clin Vaccine Immunol. 2008; 15(8):1222-8.
PMID: 18579693
PMC: 2519302.
DOI: 10.1128/CVI.00491-07.
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.
Glenn G, Villar C, Flyer D, Louis Bourgeois A, McKenzie R, Lavker R
Infect Immun. 2007; 75(5):2163-70.
PMID: 17261601
PMC: 1865773.
DOI: 10.1128/IAI.01740-06.
Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
McKenzie R, Louis Bourgeois A, Engstrom F, Hall E, Chang H, Gomes J
Infect Immun. 2006; 74(2):994-1000.
PMID: 16428745
PMC: 1360313.
DOI: 10.1128/IAI.74.2.994-1000.2006.
The pCoo plasmid of enterotoxigenic Escherichia coli is a mosaic cointegrate.
Froehlich B, Parkhill J, Sanders M, Quail M, Scott J
J Bacteriol. 2005; 187(18):6509-16.
PMID: 16159784
PMC: 1236633.
DOI: 10.1128/JB.187.18.6509-6516.2005.
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.
Qadri F, Svennerholm A, Faruque A, Sack R
Clin Microbiol Rev. 2005; 18(3):465-83.
PMID: 16020685
PMC: 1195967.
DOI: 10.1128/CMR.18.3.465-483.2005.
Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea.
Chapin A, Carpenter C, Dudley W, Gibson L, Pratdesaba R, Torres O
J Clin Microbiol. 2005; 43(3):1112-7.
PMID: 15750070
PMC: 1081225.
DOI: 10.1128/JCM.43.3.1112-1117.2005.
Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt.
Shaheen H, Khalil S, Rao M, Elyazeed R, Wierzba T, Peruski Jr L
J Clin Microbiol. 2004; 42(12):5588-95.
PMID: 15583286
PMC: 535259.
DOI: 10.1128/JCM.42.12.5588-5595.2004.
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.
Guerena-Burgueno F, Hall E, Taylor D, Cassels F, Scott D, Wolf M
Infect Immun. 2002; 70(4):1874-80.
PMID: 11895950
PMC: 127863.
DOI: 10.1128/IAI.70.4.1874-1880.2002.
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Yu J, Cassels F, Hammond S, Hartman A, Angov E, Corthesy B
Infect Immun. 2002; 70(3):1056-68.
PMID: 11854183
PMC: 127757.
DOI: 10.1128/IAI.70.3.1056-1068.2002.
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
Hall E, Wierzba T, Ahren C, Rao M, Bassily S, Francis W
Infect Immun. 2001; 69(5):2853-7.
PMID: 11292698
PMC: 98234.
DOI: 10.1128/IAI.69.5.2853-2857.2001.
Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults.
Cohen D, Orr N, Haim M, Ashkenazi S, ROBIN G, Green M
Infect Immun. 2000; 68(8):4492-7.
PMID: 10899847
PMC: 98356.
DOI: 10.1128/IAI.68.8.4492-4497.2000.
Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt.
Peruski Jr L, Kay B, El-Etr S, Cravioto A, Wierzba T, Rao M
J Clin Microbiol. 1999; 37(9):2974-8.
PMID: 10449484
PMC: 85425.
DOI: 10.1128/JCM.37.9.2974-2978.1999.
Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli.
Helander A, Wenneras C, Qadri F, Svennerholm A
Infect Immun. 1998; 66(9):4507-10.
PMID: 9712809
PMC: 108547.
DOI: 10.1128/IAI.66.9.4507-4510.1998.
Clonal nature of enterotoxigenic Escherichia coli serotype O6:H16 revealed by randomly amplified polymorphic DNA analysis.
Pacheco A, Soares K, de Almeida D, Viboud G, Binsztein N, Ferreira L
J Clin Microbiol. 1998; 36(7):2099-102.
PMID: 9650973
PMC: 104989.
DOI: 10.1128/JCM.36.7.2099-2102.1998.